What is Alexander Stadnyk's NPI number?

Alexander Stadnyk's National Provider Identifier (NPI) is 1043280365, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Alexander Stadnyk's specialty?

Alexander Stadnyk is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Alexander Stadnyk located?

Alexander Stadnyk's practice location on file with NPPES is 4801 Woodway Dr Ste 369w, Houston, TX 77056-1892.

What is Alexander Stadnyk's phone number?

The practice phone number listed in the NPPES registry for Alexander Stadnyk is (713) 799-9916.

Does Alexander Stadnyk accept Medicare?

Alexander Stadnyk is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Alexander Stadnyk's NPI active?

Yes — Alexander Stadnyk's NPI (1043280365) is active in the NPPES registry as of the last update on 2022-01-18.

IndividualActiveAccepts Medicare

Alexander Stadnyk, M.D.

NPI 1043280365 · Pulmonary Disease Physician · Houston, TX

Alexander Stadnyk, M.D. is a Pulmonary Disease Physician provider in Houston, TX (NPI 1043280365).

Provider details

NPI number: 1043280365
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: Yes
License: H3756 (TX)

Practice location

4801 Woodway Dr Ste 369w

Houston, TX 77056-1892

Phone: (713) 799-9916

Fax: (713) 799-9917

Street-level locationGet directions

More TX providers

Mailing address

4801 Woodway Dr Ste 369w

Houston, TX 77056-1892

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense H3756 (TX)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(77/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
843 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	333	$88
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	178	$73
Critical Care, First 30-74 Minutes99291	121	$196
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	60	$125
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204	49	$163
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	258	83
Montelukast Sodium	182	63
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	165	94
Prednisone	53	33
Desloratadine	48	24
Fluticasone Propion/Salmeterolbrand: Wixela Inhub	43	16

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$6,502 across 46 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-01-26
Last updated: 2022-01-18
Certified: 2022-01-18

Frequently asked questions

What is Alexander Stadnyk's NPI number?: Alexander Stadnyk's National Provider Identifier (NPI) is 1043280365, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Alexander Stadnyk's specialty?: Alexander Stadnyk is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Alexander Stadnyk located?: Alexander Stadnyk's practice location on file with NPPES is 4801 Woodway Dr Ste 369w, Houston, TX 77056-1892.
What is Alexander Stadnyk's phone number?: The practice phone number listed in the NPPES registry for Alexander Stadnyk is (713) 799-9916.
Does Alexander Stadnyk accept Medicare?: Alexander Stadnyk is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Alexander Stadnyk's NPI active?: Yes — Alexander Stadnyk's NPI (1043280365) is active in the NPPES registry as of the last update on 2022-01-18.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	333	$88
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	178	$73
Critical Care, First 30-74 Minutes99291	121	$196
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	60	$125
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204	49	$163
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	258	83
Montelukast Sodium	182	63
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	165	94
Prednisone	53	33
Desloratadine	48	24
Fluticasone Propion/Salmeterolbrand: Wixela Inhub	43	16

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$6,502 across 46 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments